Please ensure Javascript is enabled for purposes of website accessibility

3 Top Marijuana Stocks to Buy Right Now

By Keith Speights - May 30, 2021 at 6:08AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These stocks are in a great position to grow regardless of what happens with federal cannabis reform.

There was a sense of euphoria among many cannabis investors after Democrats regained effective control of the U.S. Senate as well as the White House. The countdown seemed to be on until major cannabis reforms were passed at the federal level. However, there haven't been any truly meaningful wins at the legislative level so far.

That doesn't mean that cannabis companies haven't made significant progress over the last few months, though. Some of them are arguably even more attractive than they were after Election Day. Here are three top marijuana stocks to buy right now.

Giant cannabis leaf in a shopping cart.

Image source: Getty Images.

Trulieve Cannabis

It wasn't all that long ago that Trulieve Cannabis (TCNNF -0.53%) was essentially a one-state cannabis operator. Granted, the company absolutely dominated the medical cannabis market in that one state -- Florida. And, sure, Trulieve had taken steps to expand into other markets. However, there were some valid reasons to be skeptical about the company's ability to replicate its success beyond Florida.

That's no longer the case. Earlier this month, Trulieve announced plans to acquire Harvest Health & Recreation (HRVSF) in an all-stock transaction valued at $2.1 billion. This deal will add operations in five additional states for Trulieve, including the fast-growing markets in Arizona and Nevada. 

The acquisition is expected to close in the third quarter of 2021. Assuming there are no roadblocks, Trulieve should soon boost its estimated total addressable market by more than 50%. The combined company will also be the most profitable U.S. multistate operator based on adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).

In the meantime, Trulieve continues to deliver sizzling growth all on its own. The company's sales more than doubled year over year in the first quarter thanks mainly to expansion in Florida. Trulieve also posted strong earnings growth. The addition of Harvest will make this winning marijuana stock even more attractive.

Jushi Holdings

Although there hasn't been tangible progress in recent months at the federal level in improving the outlook for the U.S. cannabis industry, it's a different story at the state level. For example, Virginia's legislature voted to legalize adult-use recreational marijuana. That should present a great opportunity for Jushi Holdings (JUSHF -4.23%).

Virginia isn't exactly in a hurry. The state's adult-use market won't open until 2024. However, that actually could work to Jushi's advantage.

The company already owns a medical cannabis license in northern Virginia, home to almost 30% of the state's population. Look for Jushi to build up its brand in the medical cannabis market over the next couple of years. That could give it a strong competitive position for the recreational market that's on the way.

Jushi's growth prospects aren't dependent just on Virginia, though. The company has operations in California, Illinois, Nevada, and Pennsylvania with acquisitions pending in Massachusetts and Ohio.

Scotts Miracle-Gro

Investors who might be a little skittish about buying shares of a pure-play pot stock have several appealing alternatives. I think that Scotts Miracle-Gro (SMG 2.35%) ranks as one of the best.

You're probably at least somewhat familiar with Scotts' line of consumer lawn and garden products. That business remains the company's biggest source of revenue, generating roughly three-quarters of total sales in the latest quarter.

However, Scotts' main growth driver now is its Hawthorne segment. Hawthorne is a leading supplier of hydroponics and gardening products to the cannabis industry. Its revenue soared 66% year over year in Scotts' fiscal second quarter.

CEO Jim Hagedorn said in the company's Q2 conference call, "Whether we see federal reform with this administration or not, clearly the momentum at the state level is not slowing down. We'll see more markets open and create more opportunities for growth." I think he's right.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Jushi Holdings, Scotts Miracle-Gro, and Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Scotts Miracle-Gro Company Stock Quote
The Scotts Miracle-Gro Company
$83.51 (2.35%) $1.92
Trulieve Cannabis Stock Quote
Trulieve Cannabis
$13.08 (-0.53%) $0.07
Harvest Health & Recreation Inc. Stock Quote
Harvest Health & Recreation Inc.
Jushi Holdings Inc. Stock Quote
Jushi Holdings Inc.
$1.81 (-4.23%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.